Nicolet Advisory Services, LLC Aurinia Pharmaceuticals Inc. Transaction History

Nicolet Advisory Services, LLC

  • $1.08 Billion
  • Q4 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
SELL
$7.13 - $9.49 $5,704 - $7,592
-800 Reduced 3.89%
19,750 $177,000
Q3 2023

Nov 07, 2023
SELL
$7.77 - $12.27 $3,108 - $4,908
-400 Reduced 1.91%
20,550 $159,000
Q2 2023

Aug 09, 2023
BUY
$8.96 - $11.69 $17,597 - $22,959
1,964 Added 10.34%
20,950 $202,000
Q1 2023

May 09, 2023
BUY
$5.94 - $11.27 $4,092 - $7,765
689 Added 3.77%
18,986 $208,000
Q4 2022

Feb 09, 2023
BUY
$4.11 - $8.14 $75,200 - $148,937
18,297 New
18,297 $79,000

Others Institutions Holding AUPH

# of Institutions
227
Shares Held
58.9M
Call Options Held
949K
Put Options Held
1.51M
View Full List

About Aurinia Pharmaceuticals Inc.

AUPH Quotes by TradingView
  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.14B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Nicolet Advisory Services, LLC Portfolio

Follow Nicolet Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicolet Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nicolet Advisory Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email